Halozyme Therapeutics, Inc. (BIT:1HALO)
49.94
0.00 (0.00%)
At close: Aug 6, 2025, 5:30 PM CET
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of €6.50 billion as of August 14, 2025. Its market cap has decreased by -0.32% in one year.
Market Cap
6.50B
Enterprise Value
7.35B
Revenue
1.00B
Ranking
n/a
PE Ratio
13.70
Stock Price
€49.94
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 141.66M to 6.50B, an increase of 4,490.53%. That is a compound annual growth rate of 19.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 6.50B | 10.68% |
Dec 31, 2024 | 5.88B | 33.01% |
Dec 29, 2023 | 4.42B | -38.64% |
Dec 30, 2022 | 7.20B | 44.69% |
Dec 31, 2021 | 4.98B | 5.58% |
Dec 31, 2020 | 4.71B | 104.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UniCredit | 104.91B |
Intesa Sanpaolo | 94.67B |
Enel SpA | 79.33B |
Ferrari | 67.79B |
Assicurazioni Generali | 50.84B |
Eni S.p.A. | 44.81B |
Leonardo S.p.a. | 26.00B |
Poste Italiane | 25.45B |